Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

MSD KK receives approval for Pifeltro for treating HIV-1 infection

Jan. 14, 2020

Drexel University synthesizes new HIV capsid assembly inhibitors

Jan. 10, 2020

ViiV Healthcare UK describes HIV integrase inhibitors

Jan. 9, 2020

CAPELLA trial recruits patients with HIV to evaluate add-on lenacapavir treatment

Dec. 24, 2019

Gilead evaluates GS-6207 with other antiretrovirals for HIV in new phase II study

Dec. 24, 2019

FDA issues complete response letter for long-acting cabotegravir/rilpivirine regimen for HIV

Dec. 23, 2019

Merck & Co. patents HIV integrase inhibitors

Dec. 23, 2019

New HIV integrase inhibitors identified at Shionogi

Dec. 17, 2019

New long-acting HIV-1 fusion inhibitor-based regimen developed

Dec. 13, 2019

Improbability research yields path to HIV vaccine

Dec. 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...